WWMSC
LGND icon

Wagner Wealth Management (South Carolina)’s Ligand Pharmaceuticals LGND Stock Holding History

Wagner Wealth Management (South Carolina)’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$1K Hold
8
– – ﹤0.01% 626
2018
Q2 		$1K Hold
8
– – ﹤0.01% 595
2018
Q1 		$1K Buy
+8
New +$791 ﹤0.01% 554
2017
Q4 		– Hold
0
– – – 732

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wagner Wealth Management (South Carolina)'s LGND Position: Q3 2018 in Review

Wagner Wealth Management (South Carolina) held its Ligand Pharmaceuticals (LGND) position steady in Q3 2018 at 8 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #626.

Wagner Wealth Management (South Carolina) first reported a position in LGND in Q1 2018 and has held it in 3 quarters since. 385 funds tracked by Wall St. Rank hold LGND as of Q3 2018.

  • Wagner Wealth Management (South Carolina) held 8 shares of Ligand Pharmaceuticals worth $1K as of Q3 2018.
  • Wagner Wealth Management (South Carolina) left its Ligand Pharmaceuticals share count unchanged in Q3 2018.
  • Ligand Pharmaceuticals made up ﹤0.01% of Wagner Wealth Management (South Carolina)'s portfolio in Q3 2018, its #626 holding.
  • Wagner Wealth Management (South Carolina) first reported a position in Ligand Pharmaceuticals in Q1 2018 and has held it in 3 quarters since.
  • 385 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2018.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q3 2018, filed 5 Nov 2018.